Next week's FDA decision on MDMA

The US FDA is due to rule on licensing for MDMA next week. There are a plethora of articles about this forthcoming decision. MAPS's sister organisation writes Lykos Therapeutics Announces New Initiatives and Measures for Additional Oversight for Midomafetamine-Assisted Therapy, if FDA Approved ... while Fluence's Ingmar Gorman has an article How the FDA MDMA Decision Affects Therapists and Trainers ... complete with a link to a MDMA Decision Debrief scheduled for the day following the FDA announcement ... and a series of organisations are trying to apply pressure on the FDA ... see, for example, the illustration accompanying this post and Why are there 17 pairs of Army boots lined up outside the White House? The answer has to do with PTSD — and psychedelic drugs.

For more psychedelic news and research, visit the psychedelic health professional network homepage.